Cotsarelis Presentation - PGD2 inhibition was reversed with blocker

[It's2014ComeOnAlready]

And what would that be?

Rux plus skin perturbation could be tested right now by follica but they are trying to reinvent the wheel, as Rux works on new skin.

All is my opinion-

http://www.ncbi.nlm.nih.gov/pubmed/22440736

A topical formulation that inhibits the main culprit behind MPB - PGD2. We can look forward to this before a "cure" is available.